Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Schering AG and Astex enter drug discovery collaboration

May 8, 2003

Updated phase II results for Tocosol Paclitaxel

May 8, 2003

Progress made in Bexxar review

May 8, 2003

Introgen gains license to fus1 anticancer gene

May 8, 2003

Viventia's first armed antibodies to enter phase I clinical testing

May 7, 2003

FDA grants accelerated approval of Iressa for NSCLC

May 7, 2003

Antitumor apoptolidin derivative with enhanced stability

May 7, 2003

Schering patent covers new CDK and/or GSK-3beta inhibitors

May 7, 2003

Australian authorities approve Iressa for NSCLC

May 6, 2003

Advectus reports preliminary results for preclinical brain cancer trials

May 6, 2003

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...